Rita Pfeifer

Title: Rita Pfeifer: Innovator in Chimeric Antigen Receptor Technology

Introduction

Rita Pfeifer is a prominent inventor based in Cologne, Germany. She has made significant contributions to the field of immunology through her innovative work on chimeric antigen receptors (CARs). Her research focuses on enhancing the efficacy of immune cells in targeting specific antigens.

Latest Patents

Rita Pfeifer holds a patent for a chimeric antigen receptor that includes a unique spacer comprising C2-set Ig-like domains. This invention provides a novel approach to CAR design, incorporating an antigen binding domain, a transmembrane domain, and an intracellular signaling domain. The spacer consists of C-set Ig-like domain(s), particularly from the sialic acid binding Ig-like lectin (Siglec) family. This advancement has the potential to improve the specificity and effectiveness of CAR therapies.

Career Highlights

Throughout her career, Rita has been associated with Miltenyi Biotec B.V. & Co. KG, where she has played a crucial role in developing cutting-edge technologies in the field of cell therapy. Her work has not only contributed to scientific knowledge but also to practical applications in treating various diseases.

Collaborations

Rita has collaborated with notable colleagues, including Daniel Schäfer and Ian Johnston. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Rita Pfeifer's contributions to the field of chimeric antigen receptors exemplify her dedication to advancing medical science. Her innovative patent and collaborative efforts highlight her role as a leading inventor in immunology.